Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-111,582
Closed -$4.57M 270
2018
Q3
$4.57M Sell
111,582
-9,202
-8% -$372K 1.12% 25
2018
Q2
$4.8M Buy
120,784
+170
+0.1% +$6.54K 1.08% 25
2018
Q1
$4.51M Sell
120,614
-5,118
-4% -$207K 1.03% 27
2017
Q4
$5.38M Buy
125,732
+5,639
+5% +$225K 1.16% 21
2017
Q3
$4.41M Buy
120,093
+14,284
+13% +$577K 1.18% 26
2017
Q2
$4.8M Buy
105,809
+1,950
+2% +$86.1K 1.3% 17
2017
Q1
$4.42M Buy
+103,859
New +$4.23M 1.2% 18

Other funds holding HOLX

Stanley-Laman Group's HOLX Position: Q4 2018 in Review

Stanley-Laman Group sold out of Hologic (HOLX) in Q4 2018, closing a stake of 111,582 shares — an estimated $4.57M sold.

Stanley-Laman Group first reported a position in HOLX in Q1 2017 and held it in 7 quarters. The position peaked at $5.38M in Q4 2017. 468 funds tracked by Wall St. Rank hold HOLX as of Q4 2018.

  • Stanley-Laman Group reported no remaining Hologic position as of Q4 2018 after selling out during the quarter.
  • Stanley-Laman Group sold 111,582 Hologic shares in Q4 2018, an estimated $4.57M.
  • Stanley-Laman Group first reported a position in Hologic in Q1 2017 and held it in 7 quarters.
  • Stanley-Laman Group's Hologic position peaked at $5.38M in Q4 2017.
  • 468 funds tracked by Wall St. Rank held Hologic as of Q4 2018.

Based on Stanley-Laman Group's 13F filing for Q4 2018, filed 7 Feb 2019.